SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2752– Conventional therapy  Chemotherapy  Local radiation – Immune Modulatorsoftware salesperson-6/4/2012
2751molecules in the "ipi space"..... anti-PD-1 anti-CD27 (agonist) IDO iscaram(o)uche-6/4/2012
2750BMY is going to be all over our LOCAL news tonight, with anti-PD-1 results expecscaram(o)uche-5/30/2012
2749“Although not required for earlier RA drugs, the agency now wants one radiographDewDiligence_on_SI-5/10/2012
27488-2 for safety is very good, unexpected.Miljenko Zuanic-5/9/2012
2747tofacitinib panel......... 10-0, 8-2 scaram(o)uche-5/9/2012
2746At the ongoing tofacitinib AdComm meeting, the Agency is now discussing the maliBiotech Jim-5/9/2012
2745Based on quick passing over many pages, I also think that it will be "closeMiljenko Zuanic-5/8/2012
2744I am still pondering somewhat the efficacy concerns, and read up a bit more on tBiotech Jim-5/7/2012
2743Are you backing off to some degree from the comments in siliconinvestor.com ? I DewDiligence_on_SI-5/7/2012
2742I did a pretty quick read of the documents, focusing on the FDA briefing documenBiotech Jim-5/7/2012
2741Did anyone review tofacitini AC briefing document?Miljenko Zuanic-5/7/2012
2740Yeah, but good to hear that it's launched. Thanks.scaram(o)uche-4/26/2012
2739Yes, last spring & summer, as an either/or along with ovarian for 1H12. Mestuck-4/26/2012
2738yeah..... have we heard about this, previously??...... >> A Phase II scaram(o)uche-4/26/2012
2737Nice quarter: >>WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corportuck-4/26/2012
2736>> Incyte Corporation (Nasdaq: INCY - News) announced today a European Uniscaram(o)uche-4/20/2012
2735Nice to see the human mass balance study is completed, Disposition of 14C-LY300Biotech Jim-3/10/2012
2734page update..... clinicaltrials.govscaram(o)uche-3/10/2012
2733Friedman at Cowen said he thought the YM molecule was just lower on the dosing cBiomaven-3/8/2012
2732Yes...saw taht... 150M for option right....well...well.... if PII does not lightMiljenko Zuanic-2/29/2012
2731150 million upfront...... <i>Abbott and Galapagos Announce Global Collabscaram(o)uche-2/29/2012
2730clinicaltrials.gov <i>This will be a 2-part, randomized, subject- and invscaram(o)uche-2/22/2012
2729From today's INCY Leerink Swann CC: 1. Surprised to hear that they have a quantman-2/16/2012
2728>> no mention of Jakafi? Well he's not actually sick yet, and may nevBiomaven-2/15/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News